Common use of Completeness Clause in Contracts

Completeness. i. Ensure completeness of case reporting provided to System Agency by conducting the following activities at least monthly: fully reviewing monthly data quality reports and regularly reviewing surveillance systems to identify any inconsistencies or gaps in laboratory reporting. Grantee is encouraged to implement additional methods of evaluating completeness of key reporting source reporting, after first receiving System Agency written approval. ii. Ensure HIV/AIDS case report forms are accurate and complete in accordance with guidance provided in the Texas HIV Surveillance Procedure Manual. iii. Collect reports of HIV and AIDS cases diagnosed and/or treated, which health care providers (e.g., physicians, HIV service providers, etc.) are required to make under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. iv. Collect reports of pediatric HIV and AIDS cases diagnosed and/or treated, infants born exposed to HIV, and pregnant women living with HIV diagnosed and/or treated, which health care providers (e.g., physicians, HIV service providers, etc.) and laboratories are required to make under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. Grantee is responsible for collecting the reports within Grantee’s designated Service Area. For each perinatal exposure investigated, Grantee shall complete a pediatric case report form (PCRF) along with an updated adult case report form for infant’s mother. v. Collect all required data elements to conduct HIV surveillance follow-up activities, including conducting medical record abstractions within three months of diagnosis for all patients seen in Grantee’s designated Service Area to properly report all HIV and AIDS cases diagnosed and/or treated within Grantee’s designated Service Area. vi. Conduct abstraction, the process of collecting and identifying important data required for a secondary use, on medical records requested by another jurisdiction in Texas within the timeframes outlined in the HIV Surveillance Manual. vii. Conduct an investigation to verify any reported adult and/or pediatric HIV or AIDS deaths and abstract medical chart when appropriate within Grantee’s designated Service Area. viii. Follow procedures as outlined in Texas HIV Surveillance Procedure Manual to conduct out-of-state record searches. ix. Manage all laboratory reports in TB/HIV/STD Integrated System (THISIS) Manual. As needed, maintain an efficient tracking mechanism, either by paper or electronic file, to record outcomes for all laboratory reports received by local site (including all laboratory reports received through Electronic Laboratory Report and all paper laboratory reports received directly from providers or labs). With the use of THISIS and if needed, the use of an efficient tracking mechanism, Grantee should be able to readily produce surveillance site standings at any given time (i.e., number of cases reported for the month, number of medical record abstractions completed, cases with incomplete algorithms, type of cases completed (new), update to AIDS, perinatal exposure, pregnancy update and number of cases pending along with estimated dates of completion). x. In support of molecular HIV surveillance (MHS), Grantee will complete or obtain HIV Testing and Treatment History information from the reporting provider to complete the testing and treatment history data elements on the Adult Case Report Form (ACRF).

Completeness. i. Ensure completeness of case reporting provided to System Agency by conducting the following activities at least monthly: fully reviewing monthly data quality reports and regularly reviewing surveillance systems to identify any inconsistencies or gaps in laboratory reporting. Grantee is encouraged to implement additional methods of evaluating completeness of key reporting source reporting, after first receiving System Agency written approval. ii. Ensure HIV/AIDS case report forms are accurate and complete in accordance with guidance provided in the Texas HIV Surveillance Procedure Manual. iii. Collect reports of HIV and AIDS cases diagnosed and/or treated, which health care providers (e.g., physicians, HIV service providers, etc.) are required to make complete under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. iv. Collect reports of pediatric HIV and AIDS cases diagnosed and/or treated, infants born exposed to HIV, and pregnant women living with HIV diagnosed and/or treated, which health care providers (e.g., physicians, HIV service providers, etc.) and laboratories are required to make complete under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. Grantee is responsible for collecting the reports within Grantee’s designated Service Area. For each perinatal exposure investigated, Grantee shall will complete a pediatric case report form (PCRF) ), along with an updated adult case report form for infant’s mother. v. Collect all required data elements to conduct HIV surveillance follow-up activities, including conducting medical record abstractions within three months of diagnosis for all patients seen in Grantee’s designated Service Area to properly report all HIV and AIDS cases diagnosed and/or treated within Grantee’s designated Service Area. vi. Conduct abstraction, the process of collecting and identifying important data required for a secondary use, on Abstract medical records requested by another jurisdiction in Texas within the timeframes outlined in the HIV Surveillance Manual. vii. Conduct an investigation to verify any reported adult and/or pediatric HIV or AIDS deaths and abstract medical chart when appropriate within Grantee’s designated Service Area. viii. Follow procedures as outlined in Texas HIV Surveillance Procedure Manual to conduct out-of-state record searches. ix. Manage all laboratory reports in TB/HIV/STD Integrated System (THISIS) in accordance with the Texas HIV Surveillance Procedure Manual. As needed, maintain an efficient tracking mechanism, either by paper or electronic file, to record outcomes for all laboratory reports received by local site (including all laboratory reports received through Electronic Laboratory Report and all paper laboratory reports received directly from providers or labs). With the use of THISIS and if needed, the use of an efficient tracking mechanism, Grantee should be able to readily produce surveillance site standings at any given time (i.e., number of cases reported for the month, number of medical record abstractions completed, cases with incomplete algorithms, type of cases completed (new), update to AIDS, perinatal exposure, pregnancy update and number of cases pending along with estimated dates of completion). x. In support of molecular HIV surveillance (MHS), Grantee will complete or obtain HIV Testing and Treatment History information from the reporting provider to complete the testing and treatment history data elements on the Adult Case Report Form (ACRF).

Completeness. i. Ensure completeness of case reporting provided to System Agency by conducting the following activities at least monthly: fully reviewing monthly data quality reports and regularly reviewing surveillance systems to identify any inconsistencies or gaps in laboratory reporting. Grantee is encouraged to implement additional methods of evaluating completeness of key reporting source reporting, after first receiving System Agency written approval. ii. Ensure HIV/AIDS case report forms are accurate and complete in accordance with guidance provided in the Texas HIV Surveillance Procedure Manual. iii. Collect reports of HIV and AIDS cases diagnosed and/or treated, treated which health care providers (e.g., physicians, HIV service providers, etc.) are required to make under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. iv. Collect reports of pediatric HIV and AIDS cases diagnosed and/or treated, infants born exposed to HIV, and pregnant women living with HIV diagnosed and/or treated, which health care providers (e.g., physicians, HIV service providers, etc.) and laboratories are required to make under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. Grantee is responsible for collecting the reports within Grantee’s designated Service Area. For each perinatal exposure investigated, Grantee shall will complete a pediatric case report form (PCRF) ), along with an updated adult case report form for infant’s mother. v. Collect all required data elements to conduct HIV surveillance follow-up activities, including conducting medical record abstractions within three months of diagnosis for all patients seen in Grantee’s designated Service Area to properly report all HIV and AIDS cases diagnosed and/or treated within Grantee’s designated Service Area. vi. Conduct abstraction, the process of collecting and identifying important data required for a secondary use, on Abstract medical records requested by another jurisdiction in Texas within the timeframes outlined in the HIV Surveillance Manual. vii. Conduct an investigation to verify any reported adult and/or pediatric HIV or AIDS deaths and abstract medical chart when appropriate within Grantee’s designated Service Area. viii. Follow procedures as outlined in Texas HIV Surveillance Procedure Manual to conduct out-of-state record searches. ix. Manage all laboratory reports in TB/HIV/STD Integrated System (THISIS) in accordance with the Texas HIV Surveillance Procedure Manual. As needed, maintain an efficient tracking mechanism, either by paper or electronic file, to record outcomes for all laboratory reports received by local site (including all laboratory reports received through Electronic Laboratory Report and all paper laboratory reports received directly from providers or labs). With the use of THISIS and if needed, the use of an efficient tracking mechanism, Grantee should be able to readily produce surveillance site standings at any given time (i.e., number of cases reported for the month, number of medical record abstractions completed, cases with incomplete algorithms, type of cases completed (new), update to AIDS, perinatal exposure, pregnancy update and number of cases pending along with estimated dates of completion). x. In support of molecular HIV surveillance (MHS), Grantee will complete or obtain HIV Testing and Treatment History information from the reporting provider to complete the testing and treatment history data elements on the Adult Case Report Form (ACRF).

Completeness. i. Ensure a. Grantee shall ensure completeness of case reporting provided to System Agency by conducting the following activities at least monthly: fully reviewing monthly data quality reports and regularly reviewing surveillance systems to identify any inconsistencies or gaps in laboratory reporting. Grantee is encouraged to implement additional methods of evaluating completeness of key reporting source reporting, after first receiving System Agency written approval. ii. Ensure b. Grantee shall ensure HIV/AIDS case report forms are accurate and complete in accordance with guidance provided in the Texas HIV Surveillance Procedure Manual. iii. Collect c. Grantee shall collect reports of HIV and AIDS cases diagnosed and/or or treated, which health care providers (e.g., physicians, HIV service providers, etc.) are required to make complete under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. iv. Collect d. Grantee shall collect reports of pediatric HIV and AIDS cases diagnosed and/or or treated, infants born exposed to HIV, and pregnant women living with HIV diagnosed and/or or treated, which health care providers (e.g., physicians, HIV service providers, etc.) and laboratories are required to make complete under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. Grantee is responsible for collecting the reports within Grantee’s designated Service Area. For each perinatal exposure investigated, for e. Grantee shall complete a pediatric case report form (PCRF) along with an updated adult case report form for infant’s mother. v. Collect collect all required data elements to conduct HIV surveillance follow-up activities, including conducting medical record abstractions within three months of diagnosis for all patients seen in Grantee’s designated Service Area Area, to properly report all HIV and AIDS cases diagnosed and/or or treated within Grantee’s designated Service Area. vi. Conduct abstraction, the process of collecting and identifying important data required for a secondary use, on f. Grantee shall abstract medical records requested by another jurisdiction in Texas within the timeframes outlined in the HIV Surveillance Manual. vii. Conduct g. Grantee shall conduct an investigation to verify any reported adult and/or or pediatric HIV or AIDS deaths and abstract medical chart chart, when appropriate appropriate, within Grantee’s designated Service Area. viii. Follow h. Grantee shall follow procedures as outlined in Texas HIV Surveillance Procedure Manual to conduct out-of-state record searches. ix. Manage i. Grantee shall manage all laboratory reports in TB/HIV/STD Integrated System (THISIS) Manual). As needed, maintain an efficient tracking mechanism, either by paper or electronic file, to record outcomes for all laboratory reports received by local site (including all laboratory reports received through Electronic Laboratory Report ELR and all paper laboratory reports received directly from providers or labs). With the use of THISIS and and, if needed, the use of an efficient tracking mechanism, Grantee should must be able to readily produce surveillance site standings at any given time (i.e., number of cases reported for the month, number of medical record abstractions completed, cases with incomplete algorithms, type of cases completed (new), update to AIDS, perinatal exposure, pregnancy update and number of cases pending along with estimated dates of completion). x. In support of molecular HIV surveillance (MHS), j. Grantee will shall complete or obtain HIV Testing and Treatment History information from the reporting provider provider, in support of molecular HIV surveillance (MHS), to complete the testing and treatment history data elements on the Adult Case Report Form (ACRF).

Completeness. i. Ensure Grantee shall ensure completeness of case reporting provided to System Agency by conducting the following activities at least monthly: fully reviewing monthly data quality reports and regularly reviewing surveillance systems to identify any inconsistencies or gaps in laboratory reporting. Grantee is encouraged to implement additional methods of evaluating completeness of key reporting source reporting, after first receiving System Agency written approval. ii. Ensure Grantee shall ensure HIV/AIDS case report forms are accurate and complete in accordance with guidance provided in the Texas HIV Surveillance Procedure Manual. iii. Collect Grantee shall collect reports of HIV and AIDS cases diagnosed and/or or treated, which health care providers (e.g., physicians, HIV service providers, etc.) are required to make complete under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. iv. Collect Grantee shall collect reports of pediatric HIV and AIDS cases diagnosed and/or or treated, infants born exposed to HIV, and pregnant women living with HIV diagnosed and/or or treated, which health care providers (e.g., physicians, HIV service providers, etc.) and laboratories are required to make complete under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. Grantee is responsible for collecting the reports within Grantee’s designated Service Area. For each perinatal exposure investigated, Grantee shall complete a pediatric case report form Pediatric Case Report Form (PCRF) along with an updated adult case report form Adult Case Report Form (ACRF) for infant’s mother. v. Collect . Grantee shall collect all required data elements to conduct HIV surveillance follow-up activities, including conducting medical record abstractions within three months of diagnosis for all patients seen in Grantee’s designated Service Area Area, to properly report all HIV and AIDS cases diagnosed and/or or treated within Grantee’s designated Service Area. vi. Conduct abstraction, the process of collecting and identifying important data required for a secondary use, on Grantee shall abstract medical records requested by another jurisdiction in Texas within the timeframes outlined in the HIV Surveillance Manual. vii. Conduct Grantee shall conduct an investigation to verify any reported adult and/or or pediatric HIV or AIDS deaths and abstract medical chart chart, when appropriate appropriate, within Grantee’s designated Service Area. viii. Follow Grantee shall follow procedures as outlined in Texas HIV Surveillance Procedure Manual to conduct out-of-state record searches. ix. Manage Grantee shall manage all laboratory reports in TB/HIV/STD Integrated System (THISIS) Manual). As needed, maintain an efficient tracking mechanism, either by paper or electronic file, to record outcomes for all laboratory reports received by local site (including all laboratory reports received through Electronic Laboratory Report ELR and all paper laboratory reports received directly from providers or labs). With the use of THISIS and and, if needed, the use of an efficient tracking mechanism, Grantee should must be able to readily produce surveillance site standings at any given time (i.e., number of cases reported for the month, number of medical record abstractions completed, cases with incomplete algorithms, type of cases completed (new), update to AIDS, perinatal exposure, pregnancy update and number of cases pending along with estimated dates of completion). x. In support of molecular HIV surveillance (MHS), . Grantee will shall complete or obtain HIV Testing and Treatment History information from the reporting provider provider, in support of molecular HIV surveillance (MHS), to complete the testing and treatment history data elements on the Adult Case Report Form (ACRF).

Completeness. i. Ensure completeness of case reporting provided to System Agency by conducting the following activities at least monthly: fully reviewing monthly data quality reports and regularly reviewing surveillance systems to identify any inconsistencies or gaps in laboratory reporting. Grantee is encouraged to implement additional methods of evaluating completeness of key reporting source reporting, after first receiving System Agency written approval. ii. Ensure HIV/AIDS case report forms are accurate and complete in accordance with guidance provided in the Texas HIV Surveillance Procedure Manual. iii. Collect reports of HIV and AIDS cases diagnosed and/or treated, treated which health care providers (e.g., physicians, HIV service providers, etc.) are required to make under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. iv. Collect reports of pediatric HIV and AIDS cases diagnosed and/or treated, infants born exposed to HIV, and HIV-positive pregnant women living with HIV diagnosed and/or treated, treated which health care providers (e.g., physicians, HIV service providers, etc.) and laboratories are required to make under TAC Title 25, Part 1, Chapter 97, Subchapter subchapter F, Rule §97.132. Grantee is responsible for collecting the reports within Grantee’s designated Service Area. For each perinatal exposure investigated, Grantee shall complete ensure that a pediatric case report form (PCRF) is completed along with an updated adult case report form for infant’s mother. v. Collect all required data elements to conduct HIV surveillance follow-up activities, including reviewing and conducting medical record abstractions within three months of diagnosis for all patients seen in Grantee’s designated Service Area to properly report all HIV and AIDS cases diagnosed and/or treated within Grantee’s designated Service Area. vi. Conduct abstraction, the process of collecting and identifying important data required for a secondary use, on Abstract medical records requested by another jurisdiction in Texas within the timeframes time frames outlined in the HIV Surveillance Manual. vii. Conduct an investigation to verify any reported adult and/or pediatric infant HIV or AIDS deaths and abstract medical chart when appropriate within Grantee’s designated Service Area. viii. Follow procedures as outlined in Texas HIV Surveillance Procedure Manual to conduct out-of-out of state record searches. ix. Manage all laboratory reports in TB/HIV/STD Integrated System (THISIS) Manual. As needed, maintain Maintain an efficient tracking mechanism, either by paper or electronic file, to record outcomes for all laboratory reports received by local site (including all laboratory reports received through Electronic Laboratory Report and all paper laboratory reports received directly from providers or labs). With the use of THISIS and if needed, the use of an efficient tracking mechanismmechanism in place, Grantee should be able to readily produce surveillance site standings at any given time (i.e., number of cases reported for the month, number of medical record abstractions completed, cases with incomplete algorithms, type of cases completed (completed- new), update to AIDS, perinatal exposure, pregnancy update and number of cases pending along with estimated dates of completion). Manage all laboratory reports in System Agency Lab Management System, upon implementation. x. In support For each adult case of molecular HIV surveillance (MHS)newly entered into the current HIV Surveillance reporting database, Grantee will complete or obtain HIV Testing and Treatment History information from the reporting provider to complete the testing and treatment history data elements on the Adult Case Report Form (ACRF).

Completeness. i. Ensure completeness of case reporting provided to System Agency DSHS by conducting the following activities at least monthly: fully reviewing monthly data quality reports and regularly reviewing surveillance systems to identify any inconsistencies or gaps in laboratory reporting. Grantee is encouraged to implement additional methods of evaluating completeness of key reporting source reporting, after first receiving System Agency DSHS’s written approval. ii. Ensure HIV/AIDS case report forms are accurate and complete in accordance with guidance provided in the Texas HIV Surveillance Procedure Manual. iii. Collect reports of HIV and AIDS cases diagnosed and/or treated, which health care providers (e.g., physicians, HIV service providers, etc.) are required to make complete under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. iv. Collect reports of pediatric HIV and AIDS cases diagnosed and/or treated, infants born exposed to HIV, and pregnant women living with HIV diagnosed and/or treated, which health care providers (e.g., physicians, HIV service providers, etc.) and laboratories are required to make complete under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. Grantee is responsible for collecting the reports within Grantee’s designated Service Area. For each perinatal exposure investigated, Grantee shall complete a pediatric case report form Pediatric Case Report Form (PCRF) along with an updated adult case report form Adult Case Report Form (ACRF) for infant’s mother. v. Collect all required data elements to conduct HIV surveillance follow-up activities, including conducting medical record abstractions within three months of diagnosis for all patients seen in Grantee’s designated Service Area Area, to properly report all HIV and AIDS cases diagnosed and/or treated within Grantee’s designated Service Area. vi. Conduct abstraction, the process of collecting and identifying important data required for a secondary use, on Abstract medical records requested by another jurisdiction in Texas within the timeframes outlined in the Texas HIV Surveillance Procedure Manual. vii. Conduct an investigation to verify any reported adult and/or pediatric HIV or AIDS deaths and abstract medical chart when appropriate within Grantee’s designated Service Area. viii. Follow procedures as outlined in Texas HIV Surveillance Procedure Manual to conduct out-of-state record searches. ix. Manage all laboratory reports in TB/HIV/STD Integrated System (THISIS) Manual. As needed, maintain an efficient tracking mechanism, either by paper or electronic file, to record outcomes for all laboratory reports received by local site (including all laboratory reports received through Electronic Laboratory Report ELR and all paper laboratory reports received directly from providers or labs). With the use of THISIS and and, if needed, the use of an efficient tracking mechanism, Grantee should must be able to readily produce surveillance site standings at any given time (i.e., number of cases reported for the month, number of medical record abstractions completed, cases with incomplete algorithms, type of cases completed (new), update to AIDS, perinatal exposure, pregnancy update and number of cases pending along with estimated dates of completion). x. In support of molecular HIV surveillance (MHS), Grantee will complete or obtain HIV Testing and Treatment History information from the reporting provider to complete the testing and treatment history data elements on the Adult Case Report Form (ACRF)Form.

Completeness. i. Ensure completeness of case reporting provided to System Agency by conducting the following activities at least monthly: fully reviewing monthly data quality reports and regularly reviewing surveillance systems to identify any inconsistencies or gaps in laboratory reporting. Grantee is encouraged to implement additional methods of evaluating completeness of key reporting source reporting, after first receiving System Agency written approval. ii. Ensure HIV/AIDS case report forms are accurate and complete in accordance with guidance provided in the Texas HIV Surveillance Procedure Manual. iii. Collect reports of HIV and AIDS cases diagnosed and/or treated, which health care providers (e.g., physicians, HIV service providers, etc.) are required to make complete under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. iv. Collect reports of pediatric HIV and AIDS cases diagnosed and/or treated, infants born exposed to HIV, and pregnant women living with HIV diagnosed and/or treated, which health care providers (e.g., physicians, HIV service providers, etc.) and laboratories are required to make complete under TAC Title 25, Part 1, Chapter 97, Subchapter F, Rule §97.132. Grantee is responsible for collecting the reports within Grantee’s designated Service Area. For each perinatal exposure investigated, Grantee shall will complete a pediatric case report form (PCRF) ), along with an updated adult case report form (ACRF) for infant’s mother. v. Collect all required data elements to conduct HIV surveillance follow-up activities, including conducting medical record abstractions within three months of diagnosis for all patients seen in Grantee’s designated Service Area to properly report all HIV and AIDS cases diagnosed and/or treated within Grantee’s designated Service Area. vi. Conduct abstraction, the process of collecting and identifying important data required for a secondary use, on Abstract medical records requested by another jurisdiction in Texas within the timeframes outlined in the HIV Surveillance Manual. vii. Conduct an investigation to verify any reported adult and/or pediatric HIV or AIDS deaths and abstract medical chart when appropriate within Grantee’s designated Service Area. viii. Follow procedures as outlined in Texas HIV Surveillance Procedure Manual to conduct out-of-state record searches. ix. Manage all laboratory reports in TB/HIV/STD Integrated System (THISIS) in accordance with the Texas HIV Surveillance Procedure Manual. As needed, maintain an efficient tracking mechanism, either by paper or electronic file, to record outcomes for all laboratory reports received by local site (including all laboratory reports received through Electronic Laboratory Report and all paper laboratory reports received directly from providers or labs). With the use of THISIS and if needed, the use of an efficient tracking mechanism, Grantee should be able to readily produce surveillance site standings at any given time (i.e., number of cases reported for the month, number of medical record abstractions completed, cases with incomplete algorithms, type of cases completed (new), update to AIDS, perinatal exposure, pregnancy update and number of cases pending along with estimated dates of completion). x. In support of molecular HIV surveillance (MHS), Grantee will complete or obtain HIV Testing and Treatment History information from the reporting provider to complete the testing and treatment history data elements on the Adult Case Report Form (ACRF)the(ACRF. xi.